MicroRNAs and Diabetes Mellitus Type 1.
MicroRNAs and Diabetes Mellitus Type 1.
Curr Diabetes Rev. 2021 Feb 14;:
Authors: Bahreini F, Rayzan E, Rezaei N
Abstract
Type 1 diabetes mellitus is a multifactorial, progressive, autoimmune disease with a strong genetic feature that can affect multiple organs, including kidney, eyes, and nerves. Early detection of type 1 diabetes can help critically to avoid serious damages to these organs. MicroRNAs are small RNA molecules that act in post-transcriptional gene regulation by attaching to the complementary sequence in the 3'-untranslated region of their target genes. Alterations in the expression of microRNA coding genes are extensively reported in several diseases such as type 1 diabetes. Presenting non-invasive biomarkers for early detection of type 1 diabetes by quantifying microRNAs gene expression level can be an influential step in biotechnology and medicine. This review discusses the area of microRNAs dysregulation in type 1 diabetes and affected molecular mechanisms involved in pancreatic islet cells formation and dysregulation in the expression of inflammatory elements as well as pro-inflammatory cytokines.
PMID: 33588736 [PubMed - as supplied by publisher]
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Bahreini F, Rayzan E, Rezaei N Tags: Curr Diabetes Rev Source Type: research
More News: Autoimmune Disease | Biotechnology | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Eyes | Genetics | Pancreas | Urology & Nephrology